Oncologic Drugs Advisory Committee

December 17-18, 2002

73rd Meeting

Consultants (voting):

For Bexxar:

James Donald Bridges, M.D.
Medical Director
Maryland Regional Cancer Care Rockville
40 West Gude Drive, Suite #120
Rockville, Maryland 20850

James E. Krook, M.D.
Principal Investigator
Duluth CCOP
400 East Third Street
Duluth, Minnesota 55805

For Casodex:

Peter C. Albertsen, M.D.
University of Connecticut Health Center
Chief, Division of Urology, MC 3955
263 Farmington Ave.
Farmington, Connecticut 06030

Phillip M. Hanno, M.D.
Hospital of the University of Pennsylvania
Urology Division, 3400 Spruce St.
1 Rhoads Pavilion
Philadelphia, Pennsylvania 19104

Alexander Krist, M.D.
3650 Joseph Siewick Drive
Suite 400
Fairfax, Virginia 22033

Mark P. Schoenberg, M.D.
Brady Urological Institute
Johns Hopkins Hospital
600 N. Wolfe St., Marburg 145
Baltimore, Maryland 21287

Patient Representatives (voting):

For Bexxar: Susan Krivacic Austin, Texas

For Casodex: James Anderson La Plata, Maryland

Consultant (non-voting):

For Casodex:

David Hoberman, Ph.D.
2236 40th Street N.W. #1
Washington, DC 20007

Industry Representative (non-voting)

George H. Ohye
3 Heritage Hills Court
Skillman, New Jersey 08558-2340